Biogen H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 Cambridge, MA HQ🌐 biogen.com
Does Biogen sponsor H-1B visas and green cards?
Yes. Biogen has filed 988 H-1B LCAs and 132 PERM green-card cases with the U.S. Department of Labor between FY2017 and FY2026. In FY2025–2026 Biogen filed 161 H-1B LCAs at a median base salary of $137,696, about 13% above the national H-1B median of $121,966 for the same period, and 18 green-card cases were decided.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 61 | $138k |
| FY2025 | 100 | $137k |
| FY2024 | 95 | $114k |
| FY2023 | 103 | $119k |
| FY2022 | 134 | $113k |
| FY2021 | 104 | $109k |
| FY2020 | 116 | $113k |
| FY2019 | 96 | $100k |
| FY2018 | 82 | $98k |
| FY2017 | 97 | $108k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
- 1Scientist I, Technical Development29$104k
- 2Principal Biostatistician27$119k
- 3Scientist II, Technical Development24$111k
- 4Postdoctoral Scientist15$65k
- 5Principal Analyst, Statistical Programming14$138k
- 6Sr Biostatistician14$102k
- 7Associate Scientist III, Chem & Mol Therapeutics11$72k
- 8Senior Biostatistician11$98k
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year †
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 7 | $128k |
| FY2025 | 11 | $114k |
| FY2024 | 7 | $115k |
| FY2023 | 21 | $116k |
| FY2022 | 18 | $113k |
| FY2021 | 25 | $120k |
| FY2020 | 10 | $100k |
| FY2019 | 10 | $98k |
| FY2018 | 14 | $122k |
| FY2017 | 9 | $108k |
Green-card route and outcomes
Worker backgrounds · FY2017–2024
Where their green-card (PERM) workers studied & came from
Patents
- Granted
- 141
- US patents
- Published, not yet granted
- 37
- applications
- Most recent grant
- December 7, 2021
- Top area
- Peptides87
Pay against the local market
Biogen’s 10 most-filed occupations and metros, FY2019–FY2026. Its median base salary is 113% of the local BLS median for the same work.
| Occupation | Metro | Filings | Biogen pay | Local BLS median‡ | vs market |
|---|---|---|---|---|---|
| Biochemists and Biophysicists | Boston, MA | 22 | $117,499 | $127,510 | 92% |
| Medical Scientists | Boston, MA | 20 | $125,065 | $129,230 | 97% |
| Data Scientists | Boston, MA | 20 | $156,105 | $131,830 | 118% |
| Statisticians | Boston, MA | 15 | $135,684 | $99,230 | 137% |
| Computer Occupations, All Other | Durham, NC | 14 | $125,886 | $112,548 | 112% |
| Biological Scientists, All Other | Boston, MA | 13 | $99,515 | $103,120 | 97% |
| Computer Occupations, All Other | Boston, MA | 11 | $153,826 | $106,430 | 145% |
| Operations Research Analysts | Boston, MA | 8 | $117,496 | $92,470 | 127% |
| Software Developers | Durham, NC | 7 | $130,301 | $117,647 | 111% |
| Compliance Officers | Boston, MA | 6 | $93,576 | $96,280 | 97% |
About Biogen
Biogen is a pharma & biotech company based in Cambridge, MA. It was founded in 1978. It is listed on Nasdaq as BIIB.
- Name (DOL filings)
- Biogen
- Listed
- Nasdaq: BIIB
- Incorporated in
- Delaware
- Headquarters
- 225 Binney Street, Cambridge, MA 02142
- Industry
- Pharma & biotech
- Employees (global)
- 7,500 (2025)
- Revenue FY2025
- $9.9B +2% from $9.7B
- Net income FY2025
- $1.3B -21% from $1.6B
- R&D FY2025
- $1.8B (18% of revenue)
Spends 18% of revenue on R&D, against a 222% median across the 61 Biological Products, (No Diagnostic Substances) filers we hold SEC data for.
Biogen pays a median H-1B base of $113,450 across FY2017–2026, about 6% above the typical Pharma & biotech sponsor.
H-1B sponsors similar to Biogen
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Amgen | 3,981 | 745 | $138k | 247 | 46% |
| AbbVie | 2,407 | 562 | $147k | 146 | 77% |
| Bristol Myers Squibb | 2,250 | 441 | $153k | 145 | 83% |
| Biogen | 988 | 161 | $138k | 51 | 78% |
| Moderna | 884 | 234 | $136k | 65 | 71% |
| Pfizer | 756 | 129 | $116k | 25 | 40% |
| Roche Diagnostics | 744 | 114 | $133k | 23 | 64% |
